← 產業報告目錄
AI Drug Discovery Platform Industry Research Report 2026
出版商 APO Research產業別 Software & IT Services出版日期 2026-07-04頁數 143報告編號 APO-4711172ef9
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global AI Drug Discovery Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Drug Discovery Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Drug Discovery Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Drug Discovery Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Drug Discovery Platform include Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics and Novadiscovery, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global AI Drug Discovery Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Drug Discovery Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Drug Discovery Platform Market by Company
Exscientia
Iktos
Delta4
Healx
Innoplexus
BenevolentAI
Evaxion
Genome Biologics
Novadiscovery
Nuritas
CytoReason
Turbine Simulated Cell Technologies
Atomwise
Recursion
Insilico Medicine
Relay Therapeutics
Pfizer
Janssen
AstraZeneca
Beijing Iipharma
AI Drug Discovery Platform Segment by Type
Drug Discovery
Drug Design
AI Drug Discovery Platform Segment by Application
Pharmaceutical Company
Biotech Company
Contract Research Organization
Others
AI Drug Discovery Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Drug Discovery Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 AI Drug Discovery Platform by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Drug Discovery
2.2.3 Drug Design
2.3 AI Drug Discovery Platform by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Pharmaceutical Company
2.3.3 Biotech Company
2.3.4 Contract Research Organization
2.3.5 Others
2.4 Assumptions and Limitations
3 AI Drug Discovery Platform Breakdown Data by Type
3.1 Global AI Drug Discovery Platform Historic Market Size by Type (2021-2026)
3.2 Global AI Drug Discovery Platform Forecasted Market Size by Type (2027-2032)
4 AI Drug Discovery Platform Breakdown Data by Application
4.1 Global AI Drug Discovery Platform Historic Market Size by Application (2021-2026)
4.2 Global AI Drug Discovery Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global AI Drug Discovery Platform Market Perspective (2021-2032)
5.2 Global AI Drug Discovery Platform Growth Trends by Region
5.2.1 Global AI Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 AI Drug Discovery Platform Historic Market Size by Region (2021-2026)
5.2.3 AI Drug Discovery Platform Forecasted Market Size by Region (2027-2032)
5.3 AI Drug Discovery Platform Market Dynamics
5.3.1 AI Drug Discovery Platform Industry Trends
5.3.2 AI Drug Discovery Platform Market Drivers
5.3.3 AI Drug Discovery Platform Market Challenges
5.3.4 AI Drug Discovery Platform Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top AI Drug Discovery Platform Players by Revenue
6.1.1 Global Top AI Drug Discovery Platform Players by Revenue (2021-2026)
6.1.2 Global AI Drug Discovery Platform Revenue Market Share by Players (2021-2026)
6.2 Global AI Drug Discovery Platform Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of AI Drug Discovery Platform Head Office and Area Served
6.4 Global AI Drug Discovery Platform Players, Product Type & Application
6.5 Global AI Drug Discovery Platform Manufacturers Established Date
6.6 Global AI Drug Discovery Platform Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America AI Drug Discovery Platform Market Size (2021-2032)
7.2 North America AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America AI Drug Discovery Platform Market Size by Country (2021-2026)
7.4 North America AI Drug Discovery Platform Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe AI Drug Discovery Platform Market Size (2021-2032)
8.2 Europe AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe AI Drug Discovery Platform Market Size by Country (2021-2026)
8.4 Europe AI Drug Discovery Platform Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific AI Drug Discovery Platform Market Size (2021-2032)
9.2 Asia-Pacific AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific AI Drug Discovery Platform Market Size by Country (2021-2026)
9.4 Asia-Pacific AI Drug Discovery Platform Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America AI Drug Discovery Platform Market Size (2021-2032)
10.2 South America AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America AI Drug Discovery Platform Market Size by Country (2021-2026)
10.4 South America AI Drug Discovery Platform Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa AI Drug Discovery Platform Market Size (2021-2032)
11.2 Middle East & Africa AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa AI Drug Discovery Platform Market Size by Country (2021-2026)
11.4 Middle East & Africa AI Drug Discovery Platform Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Exscientia
12.1.1 Exscientia Company Information
12.1.2 Exscientia Business Overview
12.1.3 Exscientia Revenue in AI Drug Discovery Platform Business (2021-2026)
12.1.4 Exscientia AI Drug Discovery Platform Product Portfolio
12.1.5 Exscientia Recent Developments
12.2 Iktos
12.2.1 Iktos Company Information
12.2.2 Iktos Business Overview
12.2.3 Iktos Revenue in AI Drug Discovery Platform Business (2021-2026)
12.2.4 Iktos AI Drug Discovery Platform Product Portfolio
12.2.5 Iktos Recent Developments
12.3 Delta4
12.3.1 Delta4 Company Information
12.3.2 Delta4 Business Overview
12.3.3 Delta4 Revenue in AI Drug Discovery Platform Business (2021-2026)
12.3.4 Delta4 AI Drug Discovery Platform Product Portfolio
12.3.5 Delta4 Recent Developments
12.4 Healx
12.4.1 Healx Company Information
12.4.2 Healx Business Overview
12.4.3 Healx Revenue in AI Drug Discovery Platform Business (2021-2026)
12.4.4 Healx AI Drug Discovery Platform Product Portfolio
12.4.5 Healx Recent Developments
12.5 Innoplexus
12.5.1 Innoplexus Company Information
12.5.2 Innoplexus Business Overview
12.5.3 Innoplexus Revenue in AI Drug Discovery Platform Business (2021-2026)
12.5.4 Innoplexus AI Drug Discovery Platform Product Portfolio
12.5.5 Innoplexus Recent Developments
12.6 BenevolentAI
12.6.1 BenevolentAI Company Information
12.6.2 BenevolentAI Business Overview
12.6.3 BenevolentAI Revenue in AI Drug Discovery Platform Business (2021-2026)
12.6.4 BenevolentAI AI Drug Discovery Platform Product Portfolio
12.6.5 BenevolentAI Recent Developments
12.7 Evaxion
12.7.1 Evaxion Company Information
12.7.2 Evaxion Business Overview
12.7.3 Evaxion Revenue in AI Drug Discovery Platform Business (2021-2026)
12.7.4 Evaxion AI Drug Discovery Platform Product Portfolio
12.7.5 Evaxion Recent Developments
12.8 Genome Biologics
12.8.1 Genome Biologics Company Information
12.8.2 Genome Biologics Business Overview
12.8.3 Genome Biologics Revenue in AI Drug Discovery Platform Business (2021-2026)
12.8.4 Genome Biologics AI Drug Discovery Platform Product Portfolio
12.8.5 Genome Biologics Recent Developments
12.9 Novadiscovery
12.9.1 Novadiscovery Company Information
12.9.2 Novadiscovery Business Overview
12.9.3 Novadiscovery Revenue in AI Drug Discovery Platform Business (2021-2026)
12.9.4 Novadiscovery AI Drug Discovery Platform Product Portfolio
12.9.5 Novadiscovery Recent Developments
12.10 Nuritas
12.10.1 Nuritas Company Information
12.10.2 Nuritas Business Overview
12.10.3 Nuritas Revenue in AI Drug Discovery Platform Business (2021-2026)
12.10.4 Nuritas AI Drug Discovery Platform Product Portfolio
12.10.5 Nuritas Recent Developments
12.11 CytoReason
12.11.1 CytoReason Company Information
12.11.2 CytoReason Business Overview
12.11.3 CytoReason Revenue in AI Drug Discovery Platform Business (2021-2026)
12.11.4 CytoReason AI Drug Discovery Platform Product Portfolio
12.11.5 CytoReason Recent Developments
12.12 Turbine Simulated Cell Technologies
12.12.1 Turbine Simulated Cell Technologies Company Information
12.12.2 Turbine Simulated Cell Technologies Business Overview
12.12.3 Turbine Simulated Cell Technologies Revenue in AI Drug Discovery Platform Business (2021-2026)
12.12.4 Turbine Simulated Cell Technologies AI Drug Discovery Platform Product Portfolio
12.12.5 Turbine Simulated Cell Technologies Recent Developments
12.13 Atomwise
12.13.1 Atomwise Company Information
12.13.2 Atomwise Business Overview
12.13.3 Atomwise Revenue in AI Drug Discovery Platform Business (2021-2026)
12.13.4 Atomwise AI Drug Discovery Platform Product Portfolio
12.13.5 Atomwise Recent Developments
12.14 Recursion
12.14.1 Recursion Company Information
12.14.2 Recursion Business Overview
12.14.3 Recursion Revenue in AI Drug Discovery Platform Business (2021-2026)
12.14.4 Recursion AI Drug Discovery Platform Product Portfolio
12.14.5 Recursion Recent Developments
12.15 Insilico Medicine
12.15.1 Insilico Medicine Company Information
12.15.2 Insilico Medicine Business Overview
12.15.3 Insilico Medicine Revenue in AI Drug Discovery Platform Business (2021-2026)
12.15.4 Insilico Medicine AI Drug Discovery Platform Product Portfolio
12.15.5 Insilico Medicine Recent Developments
12.16 Relay Therapeutics
12.16.1 Relay Therapeutics Company Information
12.16.2 Relay Therapeutics Business Overview
12.16.3 Relay Therapeutics Revenue in AI Drug Discovery Platform Business (2021-2026)
12.16.4 Relay Therapeutics AI Drug Discovery Platform Product Portfolio
12.16.5 Relay Therapeutics Recent Developments
12.17 Pfizer
12.17.1 Pfizer Company Information
12.17.2 Pfizer Business Overview
12.17.3 Pfizer Revenue in AI Drug Discovery Platform Business (2021-2026)
12.17.4 Pfizer AI Drug Discovery Platform Product Portfolio
12.17.5 Pfizer Recent Developments
12.18 Janssen
12.18.1 Janssen Company Information
12.18.2 Janssen Business Overview
12.18.3 Janssen Revenue in AI Drug Discovery Platform Business (2021-2026)
12.18.4 Janssen AI Drug Discovery Platform Product Portfolio
12.18.5 Janssen Recent Developments
12.19 AstraZeneca
12.19.1 AstraZeneca Company Information
12.19.2 AstraZeneca Business Overview
12.19.3 AstraZeneca Revenue in AI Drug Discovery Platform Business (2021-2026)
12.19.4 AstraZeneca AI Drug Discovery Platform Product Portfolio
12.19.5 AstraZeneca Recent Developments
12.20 Beijing Iipharma
12.20.1 Beijing Iipharma Company Information
12.20.2 Beijing Iipharma Business Overview
12.20.3 Beijing Iipharma Revenue in AI Drug Discovery Platform Business (2021-2026)
12.20.4 Beijing Iipharma AI Drug Discovery Platform Product Portfolio
12.20.5 Beijing Iipharma Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global AI Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global AI Drug Discovery Platform Revenue Market Share by Type (2021-2026)
Table 7. Global AI Drug Discovery Platform Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global AI Drug Discovery Platform Revenue Market Share by Type (2027-2032)
Table 9. Global AI Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global AI Drug Discovery Platform Revenue Market Share by Application (2021-2026)
Table 11. Global AI Drug Discovery Platform Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global AI Drug Discovery Platform Revenue Market Share by Application (2027-2032)
Table 13. Global AI Drug Discovery Platform Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global AI Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global AI Drug Discovery Platform Market Share by Region (2021-2026)
Table 16. Global AI Drug Discovery Platform Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global AI Drug Discovery Platform Market Share by Region (2027-2032)
Table 18. AI Drug Discovery Platform Industry Trends
Table 19. AI Drug Discovery Platform Industry Drivers
Table 20. AI Drug Discovery Platform Industry Opportunities and Challenges
Table 21. AI Drug Discovery Platform Market Restraints
Table 22. Global Top AI Drug Discovery Platform Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global AI Drug Discovery Platform Revenue Market Share by Players (2021-2026)
Table 24. Global AI Drug Discovery Platform Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of AI Drug Discovery Platform, Headquarters and Area Served
Table 26. Global AI Drug Discovery Platform Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global AI Drug Discovery Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America AI Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America AI Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe AI Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe AI Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific AI Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific AI Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America AI Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America AI Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa AI Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa AI Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million)
Table 45. Exscientia Company Information
Table 46. Exscientia Business Overview
Table 47. Exscientia Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 48. Exscientia AI Drug Discovery Platform Product Portfolio
Table 49. Exscientia Recent Developments
Table 50. Iktos Company Information
Table 51. Iktos Business Overview
Table 52. Iktos Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 53. Iktos AI Drug Discovery Platform Product Portfolio
Table 54. Iktos Recent Developments
Table 55. Delta4 Company Information
Table 56. Delta4 Business Overview
Table 57. Delta4 Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 58. Delta4 AI Drug Discovery Platform Product Portfolio
Table 59. Delta4 Recent Developments
Table 60. Healx Company Information
Table 61. Healx Business Overview
Table 62. Healx Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 63. Healx AI Drug Discovery Platform Product Portfolio
Table 64. Healx Recent Developments
Table 65. Innoplexus Company Information
Table 66. Innoplexus Business Overview
Table 67. Innoplexus Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 68. Innoplexus AI Drug Discovery Platform Product Portfolio
Table 69. Innoplexus Recent Developments
Table 70. BenevolentAI Company Information
Table 71. BenevolentAI Business Overview
Table 72. BenevolentAI Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 73. BenevolentAI AI Drug Discovery Platform Product Portfolio
Table 74. BenevolentAI Recent Developments
Table 75. Evaxion Company Information
Table 76. Evaxion Business Overview
Table 77. Evaxion Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 78. Evaxion AI Drug Discovery Platform Product Portfolio
Table 79. Evaxion Recent Developments
Table 80. Genome Biologics Company Information
Table 81. Genome Biologics Business Overview
Table 82. Genome Biologics Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 83. Genome Biologics AI Drug Discovery Platform Product Portfolio
Table 84. Genome Biologics Recent Developments
Table 85. Novadiscovery Company Information
Table 86. Novadiscovery Business Overview
Table 87. Novadiscovery Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 88. Novadiscovery AI Drug Discovery Platform Product Portfolio
Table 89. Novadiscovery Recent Developments
Table 90. Nuritas Company Information
Table 91. Nuritas Business Overview
Table 92. Nuritas Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 93. Nuritas AI Drug Discovery Platform Product Portfolio
Table 94. Nuritas Recent Developments
Table 95. CytoReason Company Information
Table 96. CytoReason Business Overview
Table 97. CytoReason Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 98. CytoReason AI Drug Discovery Platform Product Portfolio
Table 99. CytoReason Recent Developments
Table 100. Turbine Simulated Cell Technologies Company Information
Table 101. Turbine Simulated Cell Technologies Business Overview
Table 102. Turbine Simulated Cell Technologies Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 103. Turbine Simulated Cell Technologies AI Drug Discovery Platform Product Portfolio
Table 104. Turbine Simulated Cell Technologies Recent Developments
Table 105. Atomwise Company Information
Table 106. Atomwise Business Overview
Table 107. Atomwise Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 108. Atomwise AI Drug Discovery Platform Product Portfolio
Table 109. Atomwise Recent Developments
Table 110. Recursion Company Information
Table 111. Recursion Business Overview
Table 112. Recursion Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 113. Recursion AI Drug Discovery Platform Product Portfolio
Table 114. Recursion Recent Developments
Table 115. Insilico Medicine Company Information
Table 116. Insilico Medicine Business Overview
Table 117. Insilico Medicine Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 118. Insilico Medicine AI Drug Discovery Platform Product Portfolio
Table 119. Insilico Medicine Recent Developments
Table 120. Relay Therapeutics Company Information
Table 121. Relay Therapeutics Business Overview
Table 122. Relay Therapeutics Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 123. Relay Therapeutics AI Drug Discovery Platform Product Portfolio
Table 124. Relay Therapeutics Recent Developments
Table 125. Pfizer Company Information
Table 126. Pfizer Business Overview
Table 127. Pfizer Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 128. Pfizer AI Drug Discovery Platform Product Portfolio
Table 129. Pfizer Recent Developments
Table 130. Janssen Company Information
Table 131. Janssen Business Overview
Table 132. Janssen Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 133. Janssen AI Drug Discovery Platform Product Portfolio
Table 134. Janssen Recent Developments
Table 135. AstraZeneca Company Information
Table 136. AstraZeneca Business Overview
Table 137. AstraZeneca Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 138. AstraZeneca AI Drug Discovery Platform Product Portfolio
Table 139. AstraZeneca Recent Developments
Table 140. Beijing Iipharma Company Information
Table 141. Beijing Iipharma Business Overview
Table 142. Beijing Iipharma Revenue in AI Drug Discovery Platform Business (2021-2026) & (US$ Million)
Table 143. Beijing Iipharma AI Drug Discovery Platform Product Portfolio
Table 144. Beijing Iipharma Recent Developments
Table 145. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. AI Drug Discovery Platform Product Image
Figure 5. Global AI Drug Discovery Platform Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global AI Drug Discovery Platform Market Share by Type: 2025 VS 2032
Figure 7. Drug Discovery Product
Figure 8. Drug Design Product
Figure 9. Global AI Drug Discovery Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global AI Drug Discovery Platform Market Share by Application: 2025 VS 2032
Figure 11. Pharmaceutical Company Product
Figure 12. Biotech Company Product
Figure 13. Contract Research Organization Product
Figure 14. Others Product
Figure 15. Global AI Drug Discovery Platform Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global AI Drug Discovery Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global AI Drug Discovery Platform Market Share by Region: 2025 VS 2032
Figure 18. Global AI Drug Discovery Platform Market Share by Players in 2025
Figure 19. Global AI Drug Discovery Platform Manufacturers Established Date
Figure 20. Global Top 5 and 10 AI Drug Discovery Platform Players Market Share by Revenue in 2025
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. North America AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 23. North America AI Drug Discovery Platform Market Share by Country (2021-2032)
Figure 24. United States AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Canada AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Mexico AI Drug Discovery Platform Market Share by Country (2021-2032)
Figure 27. Europe AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Europe AI Drug Discovery Platform Market Share by Country (2021-2032)
Figure 29. Germany AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. France AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. U.K. AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Italy AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Spain AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Russia AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Netherlands AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Nordic Countries AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific AI Drug Discovery Platform Market Share by Country (2021-2032)
Figure 39. China AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Japan AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. South Korea AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India AI Drug Discovery Platform Market Share by Country (2021-2032)
Figure 44. Australia AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. China Taiwan AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. Southeast Asia AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America AI Drug Discovery Platform Market Share by Country (2021-2032)
Figure 49. Brazil AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Argentina AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Chile AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Colombia AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Peru AI Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Exscientia Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 55. Iktos Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 56. Delta4 Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 57. Healx Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 58. Innoplexus Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 59. BenevolentAI Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 60. Evaxion Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 61. Genome Biologics Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 62. Novadiscovery Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 63. Nuritas Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 64. CytoReason Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 65. Turbine Simulated Cell Technologies Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 66. Atomwise Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 67. Recursion Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 68. Insilico Medicine Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 69. Relay Therapeutics Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 70. Pfizer Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 71. Janssen Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 72. AstraZeneca Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
Figure 73. Beijing Iipharma Revenue Growth Rate in AI Drug Discovery Platform Business (2021-2026)
提及公司
ExscientiaIktosDelta4HealxInnoplexusBenevolentAIEvaxionGenome BiologicsNovadiscoveryNuritasCytoReasonTurbine Simulated Cell TechnologiesAtomwiseRecursionInsilico MedicineRelay TherapeuticsPfizerJanssenAstraZenecaBeijing Iipharma
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們